Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 2/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 7/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10338115 | 0.85 | MEN1 (0.51) | SCN1ASCN2ASCN3AMEN1KMT2A | |
| Water SCHEMBL28999761 | 0.84 | MEN1 (0.50) | SCN1ASCN2ASCN3AMEN1KMT2A | |
| SCHEMBL11339663 | 0.78 | ATM (0.35) | SCN1ASCN2ASCN3AMEN1KMT2A | |
| SCHEMBL11537447 | 0.77 | GRIN2B (0.35) | HPGDALOX15MEN1KMT2ASMN1; SMN2 | |
| Tempol Hydroxylamine SCHEMBL29161454 | 0.75 | KMT2A (0.42) | SCN1ASCN2ASCN3AMEN1KMT2A | |
| SCHEMBL28886947 | 0.74 | CYP2D6 (0.30) | — | |
| SCHEMBL28886937 | 0.74 | CYP2D6 (0.30) | — | |
| SCHEMBL17886779 | 0.72 | SCN1A (0.71) | SCN1ASCN2ASCN3AHPGDALOX15 | |
| SCHEMBL28886953 | 0.72 | OPRD1 (0.32) | SCN1ASCN2ASCN3ASMN1; SMN2 | |
| SCHEMBL11320172 | 0.72 | KMT2A (0.40) | SCN1ASCN2ASCN3AHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1178026-B1 | PROCESSES FOR PRODUCING OXIDE WITH HIGHER OXIDATION THAN ALCOHOL | OTSUKA KAGAKU KK (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-7183421-B2 | Processes for producing oxide with higher oxidation than alcohol | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2007-02-27 | — | — | US | disclosed |
| US-20050014957-A1 | Processes for producing oxide with higher oxidation than alcohol | TANAKA HIDEO (JP) | 2005-01-20 | — | — | US | disclosed |
| US-6797830-B2 | SILICA GEL CARRIES AN ALCOHOL AND AN OXIDATIVE CATALYST AND OXIDIZING THE ALCOHOL IN THE PRESENCE OF AN OXIDIZER | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2004-09-28 | — | — | US | disclosed |
| EP-1178026-A1 | PROCESSES FOR PRODUCING OXIDE WITH HIGHER OXIDATION THAN ALCOHOL | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2002-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014957-A1 | Processes for producing oxide with higher oxidation than alcohol | ADH1A, NOX4, AOX1 | SCN1A 3911/4885SCN2A 3966/4885SCN3A 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.